MGNGWXGGJQPLPX-UHFFFAOYSA-N
C44H39F3N4O4 — CID 151062799
Data last refreshed: (MolForge compound catalog, from PubChem)
About MGNGWXGGJQPLPX-UHFFFAOYSA-N
MGNGWXGGJQPLPX-UHFFFAOYSA-N (PubChem CID 151062799) has the molecular formula C44H39F3N4O4 and a molecular weight of 744.81 g/mol. Its IUPAC name is 1-[6-[2-[[3-[4-(4-heptylphenyl)-2-methoxyphenyl]-1H-indol-2-yl]oxy]phenyl]-2-pyridinyl]-5-(trifluoromethyl)pyrazole-4-carboxylic acid.
Molecular Properties
| Compound Name | MGNGWXGGJQPLPX-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 151062799 |
| Molecular Formula | C44H39F3N4O4 |
| Molecular Weight | 744.81 g/mol |
| Exact Mass | 744.29 |
| IUPAC Name | 1-[6-[2-[[3-[4-(4-heptylphenyl)-2-methoxyphenyl]-1H-indol-2-yl]oxy]phenyl]-2-pyridinyl]-5-(trifluoromethyl)pyrazole-4-carboxylic acid |
| SMILES | CCCCCCCc1ccc(-c2ccc(-c3c(Oc4ccccc4-c4cccc(-n5ncc(C(=O)O)c5C(F)(F)F)n4)[nH]c4ccccc34)c(OC)c2)cc1 |
| InChI | InChI=1S/C44H39F3N4O4/c1-3-4-5-6-7-13-28-20-22-29(23-21-28)30-24-25-33(38(26-30)54-2)40-32-15-8-10-16-36(32)50-42(40)55-37-18-11-9-14-31(37)35-17-12-19-39(49-35)51-41(44(45,46)47)34(27-48-51)43(52)53/h8-12,14-27,50H,3-7,13H2,1-2H3,(H,52,53) |
| InChIKey | MGNGWXGGJQPLPX-UHFFFAOYSA-N |
| XLogP | 11.78 |
| TPSA | 102.26 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 744.81 |
| LogP ≤ 5 | 11.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151062799 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.